Hormonal Optimization Stack
Endocrine fine-tuning — instead of jumping to exogenous growth hormone (which has risks), secretagogues are employed for physiological GH optimization.
Stack Overview
About This Stack
CJC-1295/Ipamorelin and Tesamorelin form this hormonal optimization combination. The CJC/Ipamorelin combo is a mainstay GH secretagogue stack that increases IGF-1 moderately for anti-aging, body composition, and skin quality. Tesamorelin (GHRH analog FDA-approved for HIV lipodystrophy) is used off-label to target visceral fat reduction and raise GH; it's potent for abdominal fat loss and also improves lipid profiles. Middle-aged men and women with hormone decline benefit from this instead of jumping to exogenous growth hormone, which carries risks. A 45-year-old executive with signs of GH deficiency (poor sleep, belly fat, low IGF-1) may do nightly CJC-1295/Ipamorelin injections — over 6 months this can improve muscle tone, reduce waist circumference, and even yield more youthful skin.
Composition
What's In This Stack
Mainstay GH secretagogue stack — CJC-1295 is a GHRH analog extending GH pulse duration; Ipamorelin is a GHRP triggering GH release with minimal side effects. Together increase IGF-1 moderately for anti-aging, body composition, and skin quality. Aiding muscle recovery, collagen synthesis, and joint integrity. Given nightly to improve GH pulses during deep sleep.
Dose: Combined SC injection nightly before sleep
Route: Subcutaneous (nightly)
GHRH analog FDA-approved for HIV lipodystrophy — used off-label to target visceral fat reduction and raise GH. Potent for abdominal fat loss and also improves lipid profiles. Particularly used in men with metabolic syndrome (to shrink visceral adiposity) and in fitness enthusiasts prepping for photoshoots for abdominal definition. In RECODEX terms, it helps recode the body's composition setpoint.
Dose: 1–2 mg SC daily
Route: Subcutaneous (daily)
Protocol
Treatment Protocol
CJC-1295 + Ipamorelin SC nightly ongoing (many patients do this for 6–12 months). Tesamorelin SC daily for 3–6 month courses targeting visceral adiposity. For those who cannot inject daily, there is an oral secretagogue alternative (MK-677 ibutamoren) — EmerGPT can suggest with caution toward increased appetite side effect. Monitoring: IGF-1 levels (ensure high-normal range, not excessive), fasting glucose (GH can increase glucose), and body composition scans (DEXA). Alternatives considered: for those who cannot inject daily, oral secretagogues are an option. Women concerned about aging but wary of HGH also benefit from the gentler secretagogues; in women, GH supports bone density which is key post-menopause.
Patient Fit
Ideal For
- Middle-aged men and women with signs of GH decline (poor sleep, belly fat, low IGF-1)
- 45-year-old executive archetype with hormonal deficiency
- Women post-menopause needing bone density and skin support
- Men with metabolic syndrome and visceral adiposity (Tesamorelin)
- Fitness enthusiasts and photoshoot prep (abdominal definition)
Results
Clinical Outcomes
Over 6 months of CJC/Ipamorelin nightly: improved muscle tone, reduced waist circumference, and more youthful skin reported. Women concerned about aging but wary of HGH benefit from gentler secretagogues; in women, GH supports bone density, key post-menopause. Tesamorelin is particularly effective in men with metabolic syndrome — shrinks visceral adiposity and improves lipid profiles. Body composition scans (DEXA) and IGF-1 levels tracked. Alternatives considered for adherence issues (MK-677 oral, though with caution toward appetite side effects). The expected outcome is not just cosmetic but functional: improved sleep quality (GH pulses during deep sleep), better recovery from workouts, and sustained body composition changes.
Begin Your RECODEX™ Protocol
All peptide stacks are physician-supervised and custom-tailored.
Request Consultation
